Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: 7 - What They Never Told You

CVS seeks verification on drugs with possible abortion use

CVS Health is asking pharmacists in some states to verify that a few of the prescriptions they provide will not be used end a pregnancy

The Independent UK

Check Out What Whales Are Doing With CVS

Someone with a lot of money to spend has taken a bearish stance on CVS Health (NYSE:CVS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Amazon, Rite Aid cap purchase of emergency contraceptives

Amazon is limiting how many emergency contraceptives consumers can buy, joining other retailers who put in place similar caps following the Supreme Court decision overruling Roe v. Wade

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Ominous Death Cross Forms On CVS Health's Chart

If history is any guide, there may be trouble ahead for shares of CVS Health (NYSE:CVS). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Can You Guess Which County Was Named The Healthiest Community?

For the third year in a row, Los Alamos County in New Mexico was named the Healthiest Community in the U.S. in an annual national ranking published by U.S. News & World Report and CVS Health (NYSE: CVS).

Benzinga

Analyst Ratings for CVS Health

Over the past 3 months, 5 analysts have published their opinion on CVS Health (NYSE:CVS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

DeSantis defends state decision not to order COVID vaccines for young kids

Gov. Ron DeSantis on Thursday defended the state’s decision not to preorder COVID-19 pediatric vaccines for children under 5, saying that parents who want the shots can access them without the state’s help.

Miami Herald

Read news from The Economist, FT, and more,
with one subscription

Peering Into CVS Health's Recent Short Interest

CVS Health's (NYSE:CVS) short percent of float has fallen 6.6% since its last report. The company recently reported that it has 12.97 million shares sold short, which is 0.99% of all regular shares that are available for trading.

Benzinga

$100 Invested In This Stock 20 Years Ago Would Be Worth $600 Today

CVS Health (NYSE:CVS) has outperformed the market over the past 20 years by 2.19% on an annualized basis producing an average annual return of 8.99%. Currently, CVS Health has a market capitalization of $122.80 billion.

Benzinga

This Is What Whales Are Betting On CVS Health

A whale with a lot of money to spend has taken a noticeably bearish stance on CVS Health. Looking at options history for CVS Health (NYSE:CVS) we detected 11 strange trades.

Benzinga

Little Village community members demand CVS Pharmacy stay open

The Little Village store is one of 900 pharmacies being closed nationwide over the next three years.

Chicago Sun-Times

Benzinga's Top Ratings Upgrades, Downgrades For May 27, 2022

Upgrades

Benzinga

Where CVS Health Stands With Analysts

CVS Health (NYSE:CVS) has observed the following analyst ratings within the last quarter:

Benzinga

If You Invested $1000 In CVS Health 20 Years Ago, Here's How Much You Would Have Today

CVS Health (NYSE:CVS) has outperformed the market over the past 20 years by 2.69% on an annualized basis producing an average annual return of 9.39%. Currently, CVS Health has a market capitalization of $126.32 billion.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Defensive Stocks to Consider Buying During the Market Downturn

The Fed’s aggressive interest rate increases to fight high inflation has raised concerns about a potential recession. During times of market turmoil, companies in defensive sectors will likely perform better than the broader market owing to inelastic demand for their products. Thus, we think it could be profitable now to…

Benzinga

CVS Health Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on CVS Health. Looking at options history for CVS Health (NYSE:CVS) we detected 21 strange trades.

The Independent UK

CVS exec: People deserve fair shot at being healthy

The new chief health equity officer at CVS Health hopes she will have more influence in fixing care disparities before they land patients in the hospital

Benzinga

Where CVS Health Stands With Analysts

CVS Health (NYSE:CVS) has observed the following analyst ratings within the last quarter:

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

CVS Health's Return On Capital Employed Overview

According to Benzinga Pro, during Q1, CVS Health (NYSE:CVS) earned $2.31 billion, a 78.47% increase from the preceding quarter. CVS Health also posted a total of $76.83 billion in sales, a 0.29% increase since Q4.

Chicago Tribune

Want free, at-home COVID-19 tests from pharmacies and insurers? It’s not always easy, despite requirements

CHICAGO -- Some Illinois residents say they’re still having trouble getting free at-home COVID-19 tests from pharmacies and insurance companies, more than three months after the White House began requiring insurers to cover them.

Benzinga

Why CVS Health Shares Are Rising

CVS Health Corp (NYSE: CVS) shares are trading higher by 3.97% at $99.79 after the company reported better-than-expected first-quarter EPS and sales results. The company also raised its FY22 EPS guidance.

Benzinga

Check Out What Whales Are Doing With CVS

Benzinga

CVS Health Q1 Earnings Beat Street Expectations, Raises FY22 Adjusted EPS Forecast

CVS Health Corp's (NYSE:CVS) Q1 sales increased 11.2% Y/Y to $76.83 billion, beating the consensus of $75.39 billion. Adjusted operating income increased 6.6% to $4.48 billion primarily due to increased prescription and front store volume, including the sale of COVID-19 OTC test kits and the impact of COVID-19 vaccinations in the Retail/LTC…

Benzinga

CVS Health: Q1 Earnings Insights

CVS Health (NYSE:CVS) reported its Q1 earnings results on Wednesday, May 4, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Benzinga

How Markets Are Playing CVS Health, T-Mobile US

On CNBC's "Options Action," Carter Worth said CVS Health Corp (NYSE: CVS) “acts poorly going into earnings.” He added, “If you’re long, we’ll take measures.

1 … 5 6 7 8

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.